{{header
 | author     = Bill Cassidy
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month      = 03
 | day        = 18
 | notes      = ''{{USBill|113|H.R.|1239}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = Accessing Medicare Therapies Act of 2013 ( H.R. 1239; 113th Congress)
 | bill       = 1239
 | billtype   = hr
 | purpose    = To amend part D of title XVIII of the Social Security Act to count the negotiated price of drugs provided free or at nominal charge under compassionate treatment programs towards incurred out-of-pocket costs.
 | wikipedia  =
}}

{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|H. R. 1239}}


{{Center|IN THE HOUSE OF REPRESENTATIVES}}


{{Center|March 18, 2013}}


{{Center|
[[w:Bill Cassidy|Mr. Cassidy]] (for himself and
[[w:Doris Matsui|Ms. Matsui]] ) introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]] , and in addition to the Committee on [[w:United States House Committee on Ways and Means|Ways and Means]] , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned}}


{{Center|A BILL}}

To amend part D of title XVIII of the Social Security Act to count the negotiated price of drugs provided free or at nominal charge under compassionate treatment programs towards incurred out-of-pocket costs.

=Section 1. Short title=

This Act may be cited as the “Accessing Medicare Therapies Act of 2013” .

=Sec. 2. Counting the negotiated price of drugs provided free or at nominal charge under compassionate treatment programs towards incurred out-of-pocket costs=



==(a) In general– ==

 Section 1860D–2(b)(4) of the Social Security Act( [http://www.law.cornell.edu/uscode/text/42/1395w–102 42 U.S.C. 1395w–102(b)(4)] )is amended—
:(1) in subparagraph (C), by striking “ subparagraph (E)” and inserting “ subparagraphs (E)and (F)” ; and
:(2) by adding at the end the following new subparagraph:

<blockquote>

====(F) Inclusion of negotiated price of drugs provided under compassionate treatment programs– ====



=====(i) In general– =====

In applying subparagraph (A)with respect to an individual enrolled in a prescription drug plan, incurred costs shall include the negotiated price described in clause (ii)of a covered part D drug if—
:(I) the drug is classified, for purposes of applying tiered copayments consistent with section 1860D–2(b)(2)(B), in the highest copayment tier (such as a tier 4 for specialty brand-name drugs);
:(II) the drug is furnished to the individual free or at nominal charge under a compassionate treatment program (as defined in clause (iii)); and
:(III) the drug, if furnished other than through such program, is covered under the formulary of the plan or is available through exception or appeal.

=====(ii) Negotiated price– =====

The negotiated price described in this clause, for a covered part D drug which is dispensed to an enrollee—
:(I) by a pharmacy, is the negotiated price at such pharmacy; or
:(II) other than by a pharmacy, is the average negotiated price for the drug in the prescription drug plan in the zip code of the enrollee as of the date the drug is dispensed.

=====(iii) Compassionate treatment program defined– =====

In this subparagraph, the term compassionate treatment program means, with respect to covered part D drugs, a program that—
:(I) is administered by an entity described in  [http://www.law.cornell.edu/uscode/text/26/501 section 501(c)(3)] of the Internal Revenue Code of 1986that is exempt from tax under section 501(a) of such Code;
:(II) takes title to the drugs and distributes the drugs to eligible part D individuals free or at nominal charge on the basis of the entity’s assessment of financial need of such individuals;
:(III) does not distribute the drugs to an individual unless the individual’s household income (as determined under  [http://www.law.cornell.edu/uscode/text/26/36B section 36B] of the Internal Revenue Code of 1986) is less than the maximum income level for the taxpayer in the household to be eligible for a refundable credit under such section; and
:(IV) meets such additional requirements as the [[w:Office of the Inspector General|Inspector General of the Department of Health and Human Services]] establishes, consistent with guidance and advisory opinions issued under section 1128D, to prevent fraud or abuse in the application of this subparagraph..
</blockquote>


==(b) Effective date– ==

The amendments made by subsection (a)shall apply to drugs furnished in plan years beginning on or after January 1, 2014.
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
